<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         dtd-version="1.1"
         xml:lang="en"
         article-type="other">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="nlm-ta">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="doi">Zdrav Vestn</journal-id>
         <journal-title-group>
            <journal-title>Slovenian Medical Journal</journal-title>
            <trans-title-group xml:lang="sl">
               <trans-title>Zdravniški vestnik</trans-title>
            </trans-title-group>
            <abbrev-journal-title>Zdrav Vestn</abbrev-journal-title>
         </journal-title-group>
         <issn publication-format="ppub" pub-type="ppub">1318-0347</issn>
         <issn publication-format="epub" pub-type="epub">1581-0224</issn>
         <issn-l>0350-0063</issn-l>
         <publisher>
            <publisher-name xml:lang="sl">Slovensko zdravniško društvo</publisher-name>
            <publisher-name xml:lang="en">Slovenian Medical Association</publisher-name>
            <publisher-loc xml:lang="sl">Ljubljana, Slovenia</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.6016/ZdravVestn.2872</article-id>
         <article-id pub-id-type="publisher-id">2872</article-id>
         <article-categories>
            <subj-group subj-group-type="discipline" xml:lang="en">
               <subject>Medicine and health sciences</subject>
               <subj-group>
                  <subject>Cardiovascular system</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="discipline" xml:lang="sl">
               <subject>Medicina/Zdravstvo</subject>
               <subj-group>
                  <subject>Srce in ožilje</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="en">
               <subject>Short scientific article</subject>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="sl">
               <subject>Klinični primer</subject>
            </subj-group>
            <subj-group subj-group-type="heading" xml:lang="en">
               <subject>Cardiovascular system</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title xml:lang="en">Percutaneous closure of patent foramen ovale and atrial septal defect: A case report</article-title>
            <trans-title-group>
               <trans-title xml:lang="sl">Perkutano zapiranje odprtega ovalnega okna in okvare medpreddvornega pretina: Prikaz primera</trans-title>
            </trans-title-group>
            <alt-title alt-title-type="running-head" xml:lang="en">Percutaneous closure of interatrial defects</alt-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Rojko</surname>
                  <given-names>Maja</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="corresp" rid="corr"/>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Černič Šuligoj</surname>
                  <given-names>Nataša</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="aff" rid="aff2">2</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Zorc</surname>
                  <given-names>Metka</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Kar</surname>
                  <given-names>Saibal</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Noč</surname>
                  <given-names>Marko</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="aff" rid="aff3">3</xref>
            </contrib>
         </contrib-group>
         <aff id="aff1" xml:lang="en">
            <label>1</label>
            <institution>International center for cardiovascular diseases, MC Medicor, Izola, Slovenia</institution>
         </aff>
         <aff id="aff2" xml:lang="en">
            <label>2</label>
            <institution>Division of internal medicine, Izola General hospital, Izola, Slovenia</institution>
         </aff>
         <aff id="aff3" xml:lang="en">
            <label>3</label>
            <institution>Department of Intensive Internal Medicine, Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia</institution>
         </aff>
         <author-notes>
            <fn fn-type="conflict" xml:lang="en">
               <p>The authors have declared that no competing interests exist.</p>
            </fn>
            <fn fn-type="conflict" xml:lang="sl">
               <p>Avtorji so izjavili, da ne obstajajo nobeni konkurenčni interesi.</p>
            </fn>
            <corresp id="corr">Maja Rojko, e-mail: <email xlink:type="simple"/>
            </corresp>
         </author-notes>
         <pub-date pub-type="ppub">
            <month>12</month>
            <year>2019</year>
         </pub-date>
         <pub-date pub-type="epub">
            <month>12</month>
            <year>2019</year>
         </pub-date>
         <volume>88</volume>
         <issue>11–12</issue>
         <fpage>576</fpage>
         <lpage>81</lpage>
         <history>
            <date date-type="received">
               <day>17</day>
               <month>9</month>
               <year>2018</year>
            </date>
            <date date-type="accepted">
               <day>15</day>
               <month>3</month>
               <year>2019</year>
            </date>
         </history>
         <permissions>
            <copyright-statement xml:lang="en">Copyright © 2019, Slovenian Medical Association (SZD)</copyright-statement>
            <copyright-statement xml:lang="sl">© 2019, Slovensko zdravniško društvo (SZD)</copyright-statement>
            <copyright-year>2019</copyright-year>
            <copyright-holder xml:lang="en">Slovenian Medical Association (SZD)</copyright-holder>
            <copyright-holder xml:lang="sl">Slovensko zdravniško društvo (SZD)</copyright-holder>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="en">
               <license-p>This is an open access article distributed under the terms of the
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Attribution-NonCommercial
            License</ext-link>, which permits unrestricted use, distribution, and
          reproduction in any medium, provided the original author and source are
          credited and only for non-commercial purposes. </license-p>
            </license>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="sl">
               <license-p>To je članek z odprtim dostopom, ki ga lahko uporabite pod pogoji iz
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Priznanje avtorstva-Nekomercialno
            licence</ext-link>. ki dovoljuje distribucijo, predelavo ali
          prilagoditev, ter gradijo na njem, v nekomercialne namene, z navedbo avtorja
          in izvirnega dela.</license-p>
            </license>
         </permissions>
         <abstract xml:lang="en">
            <title>Abstract</title>
            <p>A 67-year old man with a haemodynamically significant type secundum atrial septal defect (ASD), large patent foramen ovale (PFO) and a significant septal aneurism presented with shortness of breath and limited exercise tolerance. There was no evidence of additional structural abnormalities or significant coronary artery disease. Simultaneous percutaneous closure of both defects was planned. Since the wire could only be passed through PFO while the second wire could not be passed through the ASD, only PFO was closed with a 35 mm Amplatz PFO occluder. After 3 months, which served for tissue ingrowth of Amplatz PFO occluder and aneurism stabilization, ASD located in the posterior-inferior part of the fossa ovalis documented by three-dimensional transesophageal echocardiography (3D-TEE) was easily crossed and successfully closed with a 12 mm Amplatz ASD occluder. Stable position without unwanted interference between the devices was obtained. There was no residual shunting on colour Doppler and no bubble shunting during Valsalva maneuver. Within 6 months after the procedure, symptoms significantly improved and the right heart chambers decreased. 3D-TEE revealed both devices in good position with only trivial shunting through the PFO occluder documented by colour Doppler.</p>
         </abstract>
         <trans-abstract xml:lang="sl">
            <title>Izvleček</title>
            <p>67-letnega moškega s pomembno hemodinamsko okvaro medpreddvornega pretina (ASD) tipa secundum v kombinaciji z velikim odprtim ovalnim oknom (PFO) in anevrizmo medpreddvornega pretina smo obravnavali zaradi težkega dihanja med naporom in omejene telesne zmogljivosti. Dodatnih strukturnih nepravilnosti ali pomembne koronarne bolezni nismo potrdili. Načrtovali smo sočasno perkutano zapiranje obeh okvar. Z žico smo prečkali PFO, z drugo žico pa preko ASD nismo uspeli priti. Zato smo zaprli PFO s 35-milimetrskim zapiralom Amplatz PFO. Po 3 mesecih, ki so služili za vraščanje zapirala in stabiliziranje anevrizme pretina, smo s tridimenzionalnim transezofagealnim ultrazvokom (3D-TEE) jasno umestili ASD, ki je bil v postero-inferiornem delu t. i. fosse ovalis. Uspešno smo ga prečkali in zaprli z 12-milimetrskim zapiralom Amplatz ASD. Obe zapirali sta bili v stabilni legi, preostalega pretoka pri barvni Dopplerjevi ultrazvočni preiskavi ali prehoda mehurčkov med Valsalvo pa ni bilo. V 6 mesecih so se simptomi pomembno izboljšali, desne srčne votline pa zmanjšale. 3D-TEE je pokazal dobro lego obeh zapiral in minimalen preostali pretok skozi PFO zapiralo.</p>
         </trans-abstract>
         <kwd-group xml:lang="sl">
            <kwd>okvara mepreddvornega pretina</kwd>
            <kwd>odprto ovalno okno</kwd>
            <kwd>perkutano zapiranje</kwd>
         </kwd-group>
         <kwd-group xml:lang="en">
            <kwd>atrial septal defect</kwd>
            <kwd>patent foramen ovale</kwd>
            <kwd>percutaneous closure</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec id="s1" sec-type="Introduction">
         <label>1</label>
         <title>Introduction</title>
         <p>Atrial septal defect (ASD) accounts for up to 30 % of all congenital heart abnormalities. There are four types including type primum, secundum, sinus venosus superior/inferior and sinus coronarius (<xref ref-type="bibr" rid="b1">1</xref>). Most of the patients with ASD are asymptomatic until their forties and early fifties (<xref ref-type="bibr" rid="b2">2</xref>) when shortness of breath and limited exercise tolerance gradually develops due to increasing left to right shunting (<xref ref-type="bibr" rid="b3">3</xref>). Only ASD type secundum is amenable for percutaneous closure which is the preferred treatment in case of appropriate anatomic characteristics.</p>
         <p>Patent foramen ovale (PFO), on the other hand, is present in about 30 % of population and may be the culprit for paradoxical embolization resulting in ischemic stroke, myocardial infarction or peripheral ischemic event (<xref ref-type="bibr" rid="b4">4</xref>). Percutaneous closure may reduce the incidence of repeat paradoxical embolization and represents an effective and safe alternative to lifelong antiaggregation or/and anticoagulation therapy in these predominantly younger patients (<xref ref-type="bibr" rid="b5">5</xref>-<xref ref-type="bibr" rid="b7">7</xref>). Large ASD or PFO is frequently associated with interatrial septal aneurism (ISA) which may make percutaneous closure more challenging and increases the risk of device embolization. We herein report a patient in whom large PFO and ASD accompanied with significant ISA were successfully closed using two Amplatz occluders implanted in sequential procedures.</p>
      </sec>
      <sec id="s2" sec-type="Case report">
         <label>2</label>
         <title>Case report</title>
         <p>A 67-year-old man with arterial hypertension and paroxysmal atrial fibrillation presented with shortness of breath and limited exercise tolerance. Several years earlier, a 7 mm ASD estimated to be hemodynamically insignificant, was documented. No additional cardiac abnormality including PFO or ISA has been documented at that time.</p>
         <p>A 12-lead electrocardiogram recorded at our institution revealed sinus rhythm with borderline first-degree AV block and signs of left ventricular hypertrophy without evidence of right bundle branch block (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Transthoracic echocardiography (TTE) showed moderately enlarged right ventricle (end-diastolic area 29 cm<sup>2</sup>) and right atrium (area 36 cm<sup>2</sup>). Left ventricle showed concentric hypertrophy, normal ejection fraction and transmitral Doppler flow pattern suggestive of mild diastolic dysfunction. Also left atrium was moderately dilated (area of 36 cm<sup>2</sup>). Transesophageal echocardiography (TEE) revealed PFO with a very long tunnel which widely opened during Valsalva maneuver and was associated with immediate massive bubble appearance in left atrium. Additionally, large ISA with oval ASD (12 × 7 mm) with significant left to right shunting (Qp/Qs 2.6:1.0) was demonstrated (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>).</p>
         <fig position="anchor" id="fig1">
            <label>Figure 1:</label>
            <caption>
               <p> 12-lead electrocardiogram recorded on admission.</p>
            </caption>
            <p>
               <graphic xlink:href="2872-web-resources/image/zdravvestn-2872-en-01.png"/>
            </p>
         </fig>
         <fig position="anchor" id="fig2">
            <label>Figure 2:</label>
            <caption>
               <p> Two-dimensional transesophageal echocardiographic view (90 degrees) on interatrial septum showing significant left to right color Doppler flow through atrial septal defect (ASD) and very long patent foramen ovale (PFO) with some in-tunnel color Doppler flow. LA = left atrium; RA = right atrium; Ao = aorta.</p>
            </caption>
            <p>
               <graphic xlink:href="2872-web-resources/image/zdravvestn-2872-en-02.png"/>
            </p>
         </fig>
         <fig position="anchor" id="fig3">
            <label>Figure 3:</label>
            <caption>
               <p> Two-dimensional transesophageal echocardiographic view (90 degrees) on interatrial septum during Valsalva maneuver showing atrial septal defect (ASD), very large patent foramen ovale (PFO) and significant aneurism of interatrial septum with large amount of abundant tissue. LA = left atrium; RA = right atrium; Ao = aorta.</p>
            </caption>
            <p>
               <graphic xlink:href="2872-web-resources/image/zdravvestn-2872-en-03.png"/>
            </p>
         </fig>
         <p>Cardiac MRI did not show additional abnormalities. Coronary angiography revealed mild nonobstructive disease. Right atrial pressure was 8/7 mm Hg (mean 5 mm), pulmonary artery pressure 38/9 mm Hg (mean 22 mm) and left atrial pressure measured by passage of the catheter through the PFO was 9/7 mm Hg (mean 6 mm Hg). Calculated Qp/Qs based on oximetry performed on room air was 1.9:1.0.</p>
         <p>Simultaneous percutaneous closure of both defects was planned. We routinely use fluoroscopy and TEE guidance under conscious sedation without endotracheal intubation (<xref ref-type="bibr" rid="b9">9</xref>-<xref ref-type="bibr" rid="b11">11</xref>). A J-tipped wire was easily passed through the PFO. The second wire, nor J-tipped not hydrophilic, could not have been passed through the ASD even when PFO was completely occluded with the sizing balloon. At that point, the decision was made to close PFO using 35 mm Amplatz PFO occluder and perform ASD closure in a staged procedure after ingrowth of the device and ISA stabilization. After 3 months, the patient was brought again to the catheterization laboratory. Three- dimensional (3-D) TEE revealed a 10 mm ASD located at infero-posterior border of fossa ovalis just below the previously implanted Amplatz PFO occluder which was in a good position (<xref ref-type="fig" rid="fig4">Figure 4</xref>). A standard J-tipped wire was this time easily passed through the ASD and following balloon sizing (<xref ref-type="fig" rid="fig5">Figure 5</xref>), a 12 mm Amplatz ASD occluder was successfully deployed. Complete closure without unwanted interference between the both devices assessed by fluoroscopy (<xref ref-type="fig" rid="fig6">Figure 6</xref>a) and 3-D TEE (<xref ref-type="fig" rid="fig6">Figure 6</xref>b)<italic> </italic>was documented. There was no residual color Doppler flow through any device or interatrial septum. The patient was discharged next morning without any complications.</p>
         <fig position="anchor" id="fig4">
            <label>Figure 4:</label>
            <caption>
               <p> Three dimensional transesophageal echocardiographic view from left atrium showing the left disk of Amplatz PFO occluder and atrial septal defect (ASD) at the infero- posterior part of fossa ovalis. Ao = aorta; MV = mitral valve.</p>
            </caption>
            <p>
               <graphic xlink:href="2872-web-resources/image/zdravvestn-2872-en-04.png"/>
            </p>
         </fig>
         <fig position="anchor" id="fig5">
            <label>Figure 5:</label>
            <caption>
               <p> Fluoroscopic view (LAO 30/2 degrees) showing Amplatz PFO occluder and wire with contrast-filled sizing balloon through the atrial septal defect (ASD).</p>
            </caption>
            <p>
               <graphic xlink:href="2872-web-resources/image/zdravvestn-2872-en-05.png"/>
            </p>
         </fig>
         <fig position="anchor" id="fig6">
            <label>Figure 6:</label>
            <caption>
               <p> Fluoroscopic (A) and three-dimensional transesophageal echocardiographic side view (B) showing both implanted Amplatz occluders in appropriate position. LA = left atrium; RA = right atrium.</p>
            </caption>
            <p>
               <graphic xlink:href="2872-web-resources/image/zdravvestn-2872-en-06.png"/>
            </p>
         </fig>
         <p>At 6 months follow up, he reported significantly decreased shortness of breath and improved exercise tolerance. He roughly estimated improvement of symptoms for about 70 % from the baseline and reported only two brief episodes of, most likely, paroxysmal atrial fibrillation.</p>
         <p>TTE showed that right ventricular area significantly decreased from 29 cm<sup>2</sup> to 15 cm<sup>2</sup> and right atrium area from 36 cm<sup>2</sup> to 28 cm<sup>2</sup>. 3-D TEE showed both closure devices in adequate position with persisting small overlap (<xref ref-type="fig" rid="fig7">Figure 7</xref>A)<italic> </italic>and trivial color flow through the Amplatz PFO occluder (<xref ref-type="fig" rid="fig7">Figure 7</xref>B)<italic>.</italic>
         </p>
         <fig position="anchor" id="fig7">
            <label>Figure 7:</label>
            <caption>
               <p> Three-dimensional transesophageal echocardiographic view from left atrium showing both implanted Amplatz occluders (A) and two dimensional echocardiographic view (90 degrees) of interatrial septum showing trivial color flow through the Amplatz PFO occluder (B) 6 months after the procedure.</p>
            </caption>
            <p>
               <graphic xlink:href="2872-web-resources/image/zdravvestn-2872-en-07.png"/>
            </p>
         </fig>
      </sec>
      <sec id="s3" sec-type="Discussion">
         <label>3</label>
         <title>Discussion</title>
         <p>We described a patient with a complex pathology of aneurismatic interatrial septum with large PFO and ASD which were successfully closed in a staged procedure using two Amplatz occluders. This case nicely illustrates the important role of TEE in such complex procedures and in particular the added value of 3-D TEE which served to accurately locate ASD and its relation to PFO occluder which stabilized ISA. Such clear imaging was essential for easy wire crossing of ASD during the staged procedure. With good cooperation between interventional cardiologist and echocardiographist, even such complex procedure becomes more predictable, safer and requires less fluoroscopy. Instead of TEE, intracardiac echocardiography (ICE) using percutaneous probe introduced via femoral vein could also have been used. We have previously described successful closure of ASD in several patients (<xref ref-type="bibr" rid="b10">10</xref>). This technology is undoubtedly more comfortable for a patient but it does not provide a 3-D image and is unfortunately associated with significant additional cost.</p>
         <p>We have developed considerable experience in PFO (<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b11">11</xref>) and ASD closure (<xref ref-type="bibr" rid="b10">10</xref>) which has been as we write, successfully performed in 213 patients using different closure devices (<xref ref-type="table" rid="table1">Table 1</xref>)<italic>. </italic>In PFO patients, who had concomitant ISA in 33 %, a 6- month closure rate assessed by TEE was in excess of 90 % without device embolization/thrombosis/pericardial effusion (<xref ref-type="bibr" rid="b9">9</xref>). In ASD patients, successful closure was achieved in all patients of whom 3 (13 %) had multiple defects requiring two</p>
         <table-wrap position="anchor" id="table1">
            <label>Table 1:</label>
            <caption>
               <p> Percutaneous structural interventions at MC Medicor between October 2006 and end of December 2017.</p>
            </caption>
            <table>
               <colgroup>
                  <col/>
                  <col/>
               </colgroup>
               <thead>
                  <tr>
                     <th/>
                     <th>Number of patients</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>PFO closure</td>
                     <td align="right">181</td>
                  </tr>
                  <tr>
                     <td>ASD closure-single defect</td>
                     <td align="right">26</td>
                  </tr>
                  <tr>
                     <td>ASD closure-multiple defects</td>
                     <td align="right">3</td>
                  </tr>
                  <tr>
                     <td>PFO + ASD closure</td>
                     <td align="right">3</td>
                  </tr>
                  <tr>
                     <td>VSD closure</td>
                     <td align="right">1</td>
                  </tr>
                  <tr>
                     <td>Left atrial appendage closure</td>
                     <td align="right">29</td>
                  </tr>
                  <tr>
                     <td>TAVI</td>
                     <td align="right">11</td>
                  </tr>
                  <tr>
                     <td>Percutaneous paravalvular leak closure</td>
                     <td align="right">1</td>
                  </tr>
                  <tr>
                     <td>Alcohol septal ablation for HOCM</td>
                     <td align="right">8</td>
                  </tr>
                  <tr>
                     <td>All percutaneous structural interventions</td>
                     <td align="right">262</td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <p>Legend: PFO = patent foramen ovale; ASD = atrial septal defect type secundum; VSD = ventricular septal defect; TAVI = transcatheter aortic valve implantation; HOCM = hypertrophic obstructive cardiomyopathy</p>
            </table-wrap-foot>
         </table-wrap>
         <p>Amplatz occluders. Only 3 of 140 PFO patients (2.1 %) presented with combined PFO/ASD defects. In one patient, both defect were successfully closed using only one, but larger device resulting in complete closure also at 6 month TEE. In a second patient, FlatStent for PFO and Amplatz for ASD were used. Despite complete initial closure, follow up TEE after 6 months demonstrated residual shunting through the PFO tunnel for which antiaggregation therapy without additional closure attempt has been advised. Also herein reported patient with only trivial shunt at 6 months will be further followed to document eventual increase in shunting. These observations indicate importance of systematic TEE follow up to document possible remodeling of the tunnel and septum after closure device(s) over time with reoccurrence of shunts. We recently demonstrated such dynamic changes after in-tunnel PFO closure using FlatStent (<xref ref-type="bibr" rid="b11">11</xref>).</p>
         <p>In conclusion, our patient illustrates the capability of current percutaneous closure procedures to achieve optimal defect closure even in complex anatomies thereby avoiding open heart surgery. It also emphasizes the need for close intraprocedural cooperation between interventional cardiologist and echocardiographist who now, with 3-D TEE, has a very valuable tool to guide percutaneous structural interventions.</p>
         <p>The patient gives his consent to the publication.</p>
      </sec>
   </body>
   <back>
      <ref-list>
         <ref id="b1">
            <label>1. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Dolenc</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Koželj</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Prokšelj</surname>
                     <given-names>K</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Najpogostejše zmote pri obravnavi odraslih bolnikov s prirojenimi srčnimi napakami</article-title>. 
                    <source>Zdrav Vestn</source>. 
                    <year>2012</year>;
                    <volume>81</volume>:
                    <fpage>312</fpage>–
                    <lpage>9</lpage>.
                    <issn>0350-0063</issn>
                </mixed-citation>
         </ref>
         <ref id="b2">
            <label>2. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Berger</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ewert</surname>
                     <given-names>P</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Atrial septal defect: waiting for symptoms remains an unsolved medical anachronism</article-title>. 
                    <source>Eur Heart J</source>. 
                    <year>2011</year>
                    <month>Mar</month>;
                    <volume>32</volume>(
                    <issue>5</issue>):
                    <fpage>531</fpage>–
                    <lpage>4</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/eurheartj/ehq377</pub-id>
                    <pub-id pub-id-type="pmid">20971748</pub-id>
                    <issn>0195-668X</issn>
                </mixed-citation>
         </ref>
         <ref id="b3">
            <label>3. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Humenberger</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Rosenhek</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gabriel</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Rader</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Heger</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Klaar</surname>
                     <given-names>U</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Benefit of atrial septal defect closure in adults: impact of age</article-title>. 
                    <source>Eur Heart J</source>. 
                    <year>2011</year>
                    <month>Mar</month>;
                    <volume>32</volume>(
                    <issue>5</issue>):
                    <fpage>553</fpage>–
                    <lpage>60</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/eurheartj/ehq352</pub-id>
                    <pub-id pub-id-type="pmid">20943671</pub-id>
                    <issn>0195-668X</issn>
                </mixed-citation>
         </ref>
         <ref id="b4">
            <label>4. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Dolenc</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cerar</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cvijić</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Prokšelj</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mirta</surname>
                     <given-names>K</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Long-term follow up after transcatheter closure of atrial septal defect and patent foramen ovale in adults</article-title>. 
                    <source>Zdrav Vestn</source>. 
                    <year>2013</year>;
                    <volume>82</volume>:
                    <fpage>809</fpage>–
                    <lpage>17</lpage>.
                    <issn>0350-0063</issn>
                </mixed-citation>
         </ref>
         <ref id="b5">
            <label>5. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Carroll</surname>
                     <given-names>JD</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Saver</surname>
                     <given-names>JL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Thaler</surname>
                     <given-names>DE</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Smalling</surname>
                     <given-names>RW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Berry</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>MacDonald</surname>
                     <given-names>LA</given-names>
                  </name>, 
                        <etal>et al</etal>.; 
                        <collab>RESPECT Investigators</collab>
                    </person-group>. 
                    <article-title>Closure of patent foramen ovale versus medical therapy after cryptogenic stroke</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2013</year>
                    <month>Mar</month>;
                    <volume>368</volume>(
                    <issue>12</issue>):
                    <fpage>1092</fpage>–
                    <lpage>100</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1301440</pub-id>
                    <pub-id pub-id-type="pmid">23514286</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
         </ref>
         <ref id="b6">
            <label>6. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Meier</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kalesan</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mattle</surname>
                     <given-names>HP</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Khattab</surname>
                     <given-names>AA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hildick-Smith</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Dudek</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <etal>et al</etal>.; 
                        <collab>PC Trial Investigators</collab>
                    </person-group>. 
                    <article-title>Percutaneous closure of patent foramen ovale in cryptogenic embolism</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2013</year>
                    <month>Mar</month>;
                    <volume>368</volume>(
                    <issue>12</issue>):
                    <fpage>1083</fpage>–
                    <lpage>91</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1211716</pub-id>
                    <pub-id pub-id-type="pmid">23514285</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
         </ref>
         <ref id="b7">
            <label>7. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Furlan</surname>
                     <given-names>AJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Reisman</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Massaro</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mauri</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Adams</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Albers</surname>
                     <given-names>GW</given-names>
                  </name>, 
                        <etal>et al</etal>.; 
                        <collab>CLOSURE I Investigators</collab>
                    </person-group>. 
                    <article-title>Closure or medical therapy for cryptogenic stroke with patent foramen ovale</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2012</year>
                    <month>Mar</month>;
                    <volume>366</volume>(
                    <issue>11</issue>):
                    <fpage>991</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1009639</pub-id>
                    <pub-id pub-id-type="pmid">22417252</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
         </ref>
         <ref id="b8">
            <label>8. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Webb</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gatzoulis</surname>
                     <given-names>MA</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Atrial septal defects in the adult: recent progress and overview</article-title>. 
                    <source>Circulation</source>. 
                    <year>2006</year>
                    <month>Oct</month>;
                    <volume>114</volume>(
                    <issue>15</issue>):
                    <fpage>1645</fpage>–
                    <lpage>53</lpage>. 
                    <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.592055</pub-id>
                    <pub-id pub-id-type="pmid">17030704</pub-id>
                    <issn>0009-7322</issn>
                </mixed-citation>
         </ref>
         <ref id="b9">
            <label>9. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Černič Šuligoj</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zorc</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Grad</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kar</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Noč</surname>
                     <given-names>M</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Perkutano zapiranje ovalnega okna-izkušnje z novejšimi tipi zapiral</article-title>. 
                    <source>Slov Kardiol</source>. 
                    <year>2011</year>;
                    <volume>8</volume>:
                    <fpage>13</fpage>–
                    <lpage>7</lpage>.
                </mixed-citation>
         </ref>
         <ref id="b10">
            <label>10. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Černič Šuligoj</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zorc</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kar</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Noč</surname>
                     <given-names>M</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Perkutano zapiranje defekta preddvornega pretina tipa sekundum pri odraslih bolnikih - naše izkušnje</article-title>. 
                    <source>Slov Kardiol</source>. 
                    <year>2012</year>;
                    <volume>9</volume>:
                    <fpage>4</fpage>–
                    <lpage>9</lpage>.
                </mixed-citation>
         </ref>
         <ref id="b11">
            <label>11. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Noc</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cernic Suligoj</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zvan</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zorc</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kar</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>.
                    <article-title>In-tunnel closure of patent foramen ovale with a FlatStent EF™</article-title>.
                    <source>Kardiol Pol</source>. 
                    <year>2015</year>;
                    <volume>73</volume>(
                    <issue>7</issue>):
                    <fpage>549</fpage>-
                    <lpage>56</lpage>. 
                    <pub-id pub-id-type="doi">10.5603/KP.a2015.0026</pub-id>
                    <pub-id pub-id-type="pmid">25733171</pub-id>
                </mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
